IWC
RYTM icon

Integrated Wealth Concepts’s Rhythm Pharmaceuticals RYTM Stock Holding History

Integrated Wealth Concepts’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Buy
+2,480
New +$241K ﹤0.01% 2067
2025
Q4 		– Sell
-2,491
Closed -$252K – 1972
2025
Q3 		$252K Buy
+2,491
New +$231K ﹤0.01% 1734

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Integrated Wealth Concepts's RYTM Position: Q1 2026 in Review

Integrated Wealth Concepts opened a new position in Rhythm Pharmaceuticals (RYTM) in Q1 2026: 2,480 shares worth $216K. The stake represents ﹤0.01% of the portfolio and ranks #2067 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in RYTM as recently as Q3 2025.

Integrated Wealth Concepts first reported a position in RYTM in Q3 2025 and has held it in 2 quarters since. The position peaked at $252K in Q3 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Integrated Wealth Concepts held 2,480 shares of Rhythm Pharmaceuticals worth $216K as of Q1 2026.
  • Rhythm Pharmaceuticals was a new Integrated Wealth Concepts position in Q1 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #2067 holding.
  • Integrated Wealth Concepts first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Integrated Wealth Concepts's Rhythm Pharmaceuticals position peaked at $252K in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.